Search Tag: Ebola
4 Diseases That Will be Eradicated in the Current Century
2017 27 Feb
Poliomyelitis The lowest annual polio prevalence seen to date was in 2016, with 37 reported cases, so this disease may well be next to be eradicated. The following world regions have been declared polio-free: The Americas (1994); Indo-West Pacific region (1997); Europe (1998); Western Pacific region, including China (2000); and Southeast Asia region (2014),... Read more
The Next Ebola: Can We Do Better?
2015 24 Nov
The human catastrophe of the Ebola epidemic that began in 2013 shocked the world’s conscience and created an unprecedented crisis. An independent panel of global experts has called for critical reforms to prevent future pandemics. The group of 19 experts, convened by the Harvard Global Health Institute (HGHI) and the London School of Hygiene & Tropical... Read more
Health Workers Not Removing Protective Garments Correctly
2015 21 Jul
A recent study published in the American Journal of Infection Control finds that only 13 percent of healthcare workers (4/30) followed all CDC recommendations for the removal of personal protective equipment (PPE) after patient care.In the current era of emerging pathogens such as Ebola virus, removal of PPE is crucial to reduce contamination of healthcare... Read more
Lessons from Ebola: Planning for Health Emergencies
2015 21 Jul
The Chicago Ebola Response Network's (CERN) response to the Ebola epidemic in 2014-2015 has provided a roadmap for how a regional public health network can anticipate and manage public health emergencies, according to a study published in the journal Clinical Infectious Diseases. CERN — composed of Rush University Medical Center, University of Chicago... Read more
Guidelines for Medical Clearance of Ebola Caregivers
2015 20 Feb
The American College of Occupational and Environmental Medicine (ACOEM) has issued new guidelines aimed at strengthening procedures for the medical clearance of designated Ebola caregivers in the nation’s hospitals. “These guidelines provide a tool that hospitals can quickly turn to, should we face new cases of Ebola patients being treated in the U.S. in... Read more
Ebola: Local Health Departments' Role in Global Crisis
2015 16 Feb
Experience with the Ebola outbreak highlights local health departments' essential role in responding to global health threats posed by infectious diseases, according to a special article in the March/April issue of the Journal of Public Health Management and Practice. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer... Read more
Diagnostics-In-A-Suitcase for Ebola
2015 13 Jan
Researchers are currently developing a lab in a suitcase that can rapidly detect Ebola virus on the spot. The Diagnostics-in-a-Suitcase is the brainchild of Dr. Ahmed Abd El Wahed, a scientist in the Unit of Infection Models at the German Primate Center (DPZ) in Gottingen, Germany. The portable lab contains all the necessary equipment and reagents... Read more
Ebola Lessons for Critical Care
2015 05 Jan
According to the editors of the American Journal of Critical Care (AJCC), the recent Ebola outbreak in West Africa offers insight as to how healthcare professionals could respond more effectively to current and future healthcare challenges. Cindy Munro, RN, PhD, ANP and Richard H. Savel, MD, the two Editors-in-Chief at AJCC review and reflect on... Read more
New Global Programme For Urban Health and Wellbeing
2014 12 Dec
World health, environmental, behavioural and social science experts have launched a major new interdisciplinary scientific collaboration that aims to achieve better health for billions of people living in fast-growing urban areas. The new global Urban Health and Wellbeing Programme has these key objectives:Empower planners and policy-makers with better... Read more
Merck Obtains Rights To Ebola Vaccine
2014 26 Nov
Merck & Co. has obtained the rights to an experimental Ebola vaccine. The vaccine has been developed by NewLink Genetics Corp. According to reports, Merck will be paying NewLink $30 million upfront plus an additional $20 million when clinical trials get under way. NewLink originally obtained this vaccine in 2010 from Canadian officials for $200,000. Early-stage... Read more
